Skip to main content


05-12-2023 | Gestational diabetes | News

Early gestational diabetes intervention improves pregnancy outcomes

Identifying and treating women with gestational diabetes before 20 weeks’ gestation improves their pregnancy outcomes, shows the randomized TOBOGM trial.

01-26-2023 | Screening | News

Age 10 years is optimal type 1 diabetes screening point for adolescents

“Almost no one” who is islet autoantibody negative at age 10 years despite a high familial risk for type 1 diabetes will develop clinical diabetes by the age of 18, report researchers.

11-21-2022 | Cancer | News

Type 2 diabetes linked to advanced stage at cancer diagnosis

Having type 2 diabetes increases a person’s risk for a cancer being already metastatic at the point of diagnosis, shows an EPIC analysis.

10-27-2022 | Screening | News

IAA screening may improve classification of autoimmune diabetes in children

Testing for autoantibodies to endogenous insulin in addition to regular autoantibody screening can increase the proportion of children with an autoimmune classification for newly diagnosed type 1 diabetes, UK research suggests.

09-05-2022 | Depression | News

Lower screening thresholds may better detect depression in adolescent type 1 diabetes

Reducing the cutoffs of commonly used depression screening measures may increase the sensitivity for detecting depression in adolescents with type 1 diabetes, US study findings indicate.

08-01-2022 | Diagnosis | News

‘Major improvements’ in diabetes detection in USA

The number of people with undiagnosed diabetes in the USA has fallen in the past 3 decades, indicates research published in Diabetes Care.

07-18-2022 | Screening | News

Guideline-concordant diabetes screening rates ‘suboptimal’

Women are more likely to attend guideline-recommended diabetes screening than men, but rates are “suboptimal” in both sexes, particularly among younger individuals, show population-based study data from Canada.

Blood test

07-08-2022 | Screening | News

Two early childhood autoantibody screenings predict most type 1 diabetes cases

Testing high-risk children for islet autoantibodies twice, at the ages of 2 and 6 years, is sufficient to predict the majority of clinical cases of type 1 diabetes diagnosed by the age of 15, a study suggests.